BIVDA Press Releases

Mar 04, 2021
Microsemi CRP LC-767G HORIBA Medical, specialists in automated in vitro diagnostic systems for haematology, haemostasis and clinical chemistry analysis, has obtained the CE Mark certification for its new generation of the Microsemi CRP haematology analyser, the Microsemi CRP LC-767G. This new generation analyser Microsemi CRP LC-767G is more compact and proposes enhanced software and network connectivity providing higher memory, usability plus a new parameter: Granulocytes-to- Lymphocy...
Read More
Mar 03, 2021
Press Release - BIVDA Comments on Budget 2021 support for life sciences  BIVDA, the trade association for British in-vitro diagnostic companies, has commented on today’s Budget announcements, outlined in the House of Commons by Chancellor Rishi Sunak.  The British IVD industry is a growing and innovative part of our economy. This Budget, coming as the health service and our economy begin to recover from the effects of the COVID-19 pandemic, offers an opportunity to ensure the IVD...
Read More
Mar 03, 2021
New England Biolabs® Introduces ARTIC Products for SARS-CoV-2 Sequencing New kits improve upon well-established ARTIC protocols for SARS-CoV-2 genome sequencing with optimized reagents and improved uniformity of coverage depth for Illumina® and Oxford Nanopore Technologies® next generation sequencing (NGS) platforms IPSWICH, Mass, February 25, 2021 — New England Biolabs (NEB®) today released three kits based on the ARTIC Network protocols ...
Read More
Mar 02, 2021
BIVDA calls for a diagnostics industry of ‘critical mass’ to help fight future health challenges  BIVDA, the trade association for British in-vitro diagnostic companies, has submitted a response to the Government’s new Innovation Taskforce, set up by the Prime Minister to identify and develop proposals across a range of areas that will drive innovation and competitiveness, reduce barriers to start-ups and scale-ups, create opportunities for innovation to make the most of c...
Read More
Feb 24, 2021
NHSEI SBRI Healthcare grant for Psyros’ rapid, ultra-sensitive test for heart attack marker Firm raising £2.5m seed round to support further development of prototypeDiscovery Park, Sandwich, UK, February 24 2021 – Psyros Diagnostics, which is developing ultra-sensitive, ultra-fast, point of care diagnostics based on single molecule counting, has been awarded a £99,400 grant by NHSEI SBRI Healthcare1 to advance their novel test for the heart attack marker troponin. Ps...
Read More
Feb 23, 2021
RANDOX PROCESSES ITS 10 MILLIONTH COVID-19 TEST AND DETAILS INVESTMENT IN TESTING CAPACITY Randox Laboratories has confirmed that it has processed its 10 millionth sample for the UK’s COVID-19 National Testing Programme, making it the first Pillar 2 testing laboratory to achieve this milestone.  This achievement is based upon a £85 million investment since March 2020 in facilities and equipment at Randox’s laboratories in Northern Ireland.  As a key partner labor...
Read More
Feb 22, 2021
BIVDA calls for investment in diagnostics to help make Britain a science superpower BIVDA, the in-vitro diagnostics trade association, has called for an economic recovery based on developing the UK as a science superpower, with a policy focus on advanced manufacturing, research & innovation, and highly skilled jobs. In its submission to Rishi Sunak, the trade association identifies three priorities for investment in the Chancellor’s financial package next month; Investment in...
Read More
Feb 18, 2021
HORIBA Medical Obtains CE Mark Certification for Microsemi CRP New Generation - Microsemi CRP LC-767G HORIBA Medical, specialists in automated in vitro diagnostic systems for haematology, haemostasis and clinical chemistry analysis, has obtained the CE Mark certification for its new generation of the Microsemi CRP haematology analyser, the Microsemi CRP LC-767G. This new generation analyser Microsemi CRP LC-767G is more compact and proposes enhanced software and network connectivity pr...
Read More
Feb 17, 2021
Revolutionise Your Pancreatic Elastase Testing with the New BÜHLMANN fPELA® turboFaecal pancreatic elastase testing can now be automated, providing flexible and random access application on most clinical chemistry platforms. The new fPELA® turbo from BÜHLMANN is ideal for use in laboratory environments for identification and monitoring of pancreatic insufficiency in patients. There is the added advantage that it utilises the same CALEX extraction device as the fCAL turbo assay,...
Read More
Feb 15, 2021
BIVDA comments on Life Science Competitiveness Report BIVDA has welcomed the publication of the Life Science Competitiveness Indicators 2020, a report that gives a comprehensive outline of the state of the UK life sciences sector covering research funding, import-export levels and investment, amongst other key indicators. Life sciences continue to be a crucial pillar of the UK economy generating almost £81bn annually and employing over 250,000 people. In terms of Government activ...
Read More
Page 1 of 9 FirstPrevious [1]